Boston Trust Walden’s Corcept Therapeutics CORT Stock Holding History

Boston Trust Walden’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.3M	Sell	440,264 -22,342	-5%	-$1.35M	0.29%	124
2026 Q1	$18.6M	Sell	462,606 -65,020	-12%	-$2.43M	0.15%	183
2025 Q4	$18.4M	Sell	527,626 -34,635	-6%	-$2.72M	0.14%	181
2025 Q3	$46.7M	Sell	562,261 -9,811	-2%	-$710K	0.34%	118
2025 Q2	$42M	Sell	572,072 -12,728	-2%	-$923K	0.3%	133
2025 Q1	$66.8M	Sell	584,800 -314,261	-35%	-$19.1M	0.49%	70
2024 Q4	$45.3M	Sell	899,061 -614,914	-41%	-$32.2M	0.32%	129
2024 Q3	$70.1M	Sell	1,513,975 -69,924	-4%	-$2.48M	0.49%	71
2024 Q2	$51.5M	Sell	1,583,899 -251,194	-14%	-$6.88M	0.38%	106
2024 Q1	$46.2M	Sell	1,835,093 -11,831	-0.6%	-$280K	0.33%	123
2023 Q4	$60M	Buy	1,846,924 +19,877	+1%	+$546K	0.45%	77
2023 Q3	$49.8M	Sell	1,827,047 -169,310	-8%	-$4.9M	0.42%	82
2023 Q2	$44.4M	Buy	1,996,357 +77,178	+4%	+$1.78M	0.36%	101
2023 Q1	$41.6M	Buy	1,919,179 +72,898	+4%	+$1.6M	0.36%	101
2022 Q4	$37.5M	Buy	1,846,281 +487,962	+36%	+$12.2M	0.33%	109
2022 Q3	$34.8M	Buy	1,358,319 +47,281	+4%	+$1.27M	0.35%	104
2022 Q2	$31.2M	Buy	1,311,038 +12,226	+0.9%	+$266K	0.29%	125
2022 Q1	$29.2M	Buy	1,298,812 +267,805	+26%	+$5.7M	0.24%	146
2021 Q4	$20.4M	Sell	1,031,007 -30,838	-3%	-$626K	0.16%	178
2021 Q3	$20.9M	Buy	1,061,845 +311,494	+42%	+$6.52M	0.19%	168
2021 Q2	$16.5M	Sell	750,351 -20,214	-3%	-$450K	0.15%	184
2021 Q1	$18.3M	Buy	770,565 +360,721	+88%	+$9.63M	0.18%	172
2020 Q4	$10.7M	Buy	+409,844	New	+$8.63M	0.11%	203

Other funds holding CORT

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Boston Trust Walden's CORT Position: Q2 2026 in Review

Boston Trust Walden reduced its Corcept Therapeutics (CORT) stake by 4.8% in Q2 2026, selling an estimated $1.35M and leaving 440,264 shares worth $38.3M. The position accounts for 0.29% of the portfolio, ranked #124.

Boston Trust Walden first reported a position in CORT in Q4 2020 and has held it in 23 quarters since. The position peaked at $70.1M in Q3 2024. 113 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Boston Trust Walden held 440,264 shares of Corcept Therapeutics worth $38.3M as of Q2 2026.
Boston Trust Walden sold 22,342 Corcept Therapeutics shares in Q2 2026, an estimated $1.35M.
Corcept Therapeutics made up 0.29% of Boston Trust Walden's portfolio in Q2 2026, its #124 holding.
Boston Trust Walden first reported a position in Corcept Therapeutics in Q4 2020 and has held it in 23 quarters since.
Boston Trust Walden's Corcept Therapeutics position peaked at $70.1M in Q3 2024.
113 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.